头孢克肟 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "头孢克肟" in Chinese language version.

refsWebsite

Global rank Chinese rank

21web.archive.org

1^st place

5nih.gov

4^th place

5^th place

4drugs.com

399^th place

208^th place

4fda.gov

447^th place

581^st place

3doi.org

2^nd place

23^rd place

2archive.org

6^th place

4^th place

2handle.net

102^nd place

492^nd place

1fdcindia.com

low place

1medicines.org.uk

3,823^rd place

3,456^th place

1books.google.com

3^rd place

8^th place

1worldcat.org

5^th place

12^th place

1toku-e.com

low place

1antimicrobe.org

low place

1drugbank.com

low place

1pipelinepharma.com

low place

1regionvasterbotten.se

low place

1mayoclinic.org

1,610^th place

2,275^th place

1cdc.gov

218^th place

198^th place

1mosaicscience.com

low place

antimicrobe.org

Cefixime. antimicrobe.org. [2024-06-28]. （原始内容存档于2024-06-28）.

archive.org

World Health Organization. Stuart MC, Kouimtzi M, Hill SR , 编. WHO Model Formulary 2008. World Health Organization. 2009: 107. ISBN 9789241547659. hdl:10665/44053 .
Matsumoto Y, Ikemoto A, Wakai Y, Ikeda F, Tawara S, Matsumoto K. Mechanism of therapeutic effectiveness of cefixime against typhoid fever. Antimicrobial Agents and Chemotherapy. September 2001, 45 (9): 2450–2454. PMC 90676 . PMID 11502513. doi:10.1128/aac.45.9.2450-2454.2001.

books.google.com

Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 495. ISBN 9783527607495.

cdc.gov

Notice to Readers: Discontinuation of Cefixime Tablets --- United States. CDC. [2024-06-28]. （原始内容存档于2024-06-28）.

doi.org

Matsumoto Y, Ikemoto A, Wakai Y, Ikeda F, Tawara S, Matsumoto K. Mechanism of therapeutic effectiveness of cefixime against typhoid fever. Antimicrobial Agents and Chemotherapy. September 2001, 45 (9): 2450–2454. PMC 90676 . PMID 11502513. doi:10.1128/aac.45.9.2450-2454.2001.
Bhutta ZA, Khan IA, Molla AM. Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone. The Pediatric Infectious Disease Journal. November 1994, 13 (11): 990–994. PMID 7845753. doi:10.1097/00006454-199411000-00010.
Abhigan Babu Shrestha, Abhigan Babu; Shrestha, Sajina. Cefixime induced Steven Johnson syndrome: A case report from Bangladesh. Annals of Medicine and Surgery. July 2022, 79 [2023]. doi:10.1016/j.amsu.2022.104089. （原始内容存档于2024-06-28）.

drugbank.com

go.drugbank.com

Cefixime. DRUGBANK Online. [2024-06-28]. （原始内容存档于2024-07-07）.

drugs.com

Cefixime—Drugs.com. www.drugs.com. [2016-12-10]. （原始内容存档于2016-05-30）.
Cefixime. The American Society of Health—System Pharmacists. [2016-12-08]. （原始内容存档于2016-11-27）.
Cefixime (Suprax) Use During Pregnancy. Drugs.com. 2019-03-29 [2019-12-24]. （原始内容存档于2016-12-20）.
Generic Suprax Availability. Drugs.com. [2020-04-23]. （原始内容存档于2020-07-27）.

fda.gov

accessdata.fda.gov

Suprax: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [2020-04-23]. （原始内容存档于2020-07-27）.
Suprax: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [2020-04-23]. （原始内容存档于2020-07-27）.
Suprax: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [2020-04-23]. （原始内容存档于2020-07-27）.
Suprax: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [2020-04-23]. （原始内容存档于2020-07-27）.

fdcindia.com

FDC—Products—Formulations. fdcindia.com. [2018-05-02]. （原始内容存档于2018-04-26）.

handle.net

hdl.handle.net

World Health Organization. Stuart MC, Kouimtzi M, Hill SR , 编. WHO Model Formulary 2008. World Health Organization. 2009: 107. ISBN 9789241547659. hdl:10665/44053 .
World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

mayoclinic.org

Cefixime (Oral Route). Mayo Clinic. [2024-06-28]. （原始内容存档于2024-06-28）.

medicines.org.uk

Suprax 200 mg Tablets - Summary of Product Characteristics (SmPC). (emc). 2019-08-20 [2020-04-23]. （原始内容存档于2020-07-27）.

mosaicscience.com

Perur S. Fake drugs: the global industry putting your life at risk. Mosaic. 2018-10-30 [2018-12-13]. （原始内容存档于2020-04-11）.

nih.gov

ncbi.nlm.nih.gov

Matsumoto Y, Ikemoto A, Wakai Y, Ikeda F, Tawara S, Matsumoto K. Mechanism of therapeutic effectiveness of cefixime against typhoid fever. Antimicrobial Agents and Chemotherapy. September 2001, 45 (9): 2450–2454. PMC 90676 . PMID 11502513. doi:10.1128/aac.45.9.2450-2454.2001.
Bhutta ZA, Khan IA, Molla AM. Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone. The Pediatric Infectious Disease Journal. November 1994, 13 (11): 990–994. PMID 7845753. doi:10.1097/00006454-199411000-00010.
Abhigan Babu Shrestha, Abhigan Babu; Shrestha, Sajina. Cefixime induced Steven Johnson syndrome: A case report from Bangladesh. Annals of Medicine and Surgery. July 2022, 79 [2023]. doi:10.1016/j.amsu.2022.104089. （原始内容存档于2024-06-28）.

dailymed.nlm.nih.gov

Suprax- cefixime tablet Suprax- cefixime capsule Suprax- cefixime tablet, chewable Suprax- cefixime powder, for suspension. DailyMed. 2019-11-26 [2020-04-23]. （原始内容存档于2020-06-03）.
Suprax- cefixime powder, for suspension. DailyMed. 2 January 2020 [23 April 2020]. （原始内容存档于2020-07-28）.

pipelinepharma.com

Cefixime Trihydrate. pipelinepharma. [2024-06-28]. （原始内容存档于2024-06-28）.

regionvasterbotten.se

PRODUCT MONOGRAPH PrSUPRAX® (PDF). ODAN LABORATORIES LTD. 2020-03-17 [2024-06-28]. （原始内容存档 (PDF)于2024-06-28）.

toku-e.com

Cefixime trihydrate Susceptibility and Minimum Inhibitory Concentration (MIC) Data (PDF). www.toku-e.com. [2024-07-11]. （原始内容存档 (PDF)于2016-03-04）.

web.archive.org

Cefixime—Drugs.com. www.drugs.com. [2016-12-10]. （原始内容存档于2016-05-30）.
FDC—Products—Formulations. fdcindia.com. [2018-05-02]. （原始内容存档于2018-04-26）.
Suprax- cefixime tablet Suprax- cefixime capsule Suprax- cefixime tablet, chewable Suprax- cefixime powder, for suspension. DailyMed. 2019-11-26 [2020-04-23]. （原始内容存档于2020-06-03）.
Suprax 200 mg Tablets - Summary of Product Characteristics (SmPC). (emc). 2019-08-20 [2020-04-23]. （原始内容存档于2020-07-27）.
Cefixime. The American Society of Health—System Pharmacists. [2016-12-08]. （原始内容存档于2016-11-27）.
Cefixime (Suprax) Use During Pregnancy. Drugs.com. 2019-03-29 [2019-12-24]. （原始内容存档于2016-12-20）.
Generic Suprax Availability. Drugs.com. [2020-04-23]. （原始内容存档于2020-07-27）.
Cefixime trihydrate Susceptibility and Minimum Inhibitory Concentration (MIC) Data (PDF). www.toku-e.com. [2024-07-11]. （原始内容存档 (PDF)于2016-03-04）.
Cefixime. antimicrobe.org. [2024-06-28]. （原始内容存档于2024-06-28）.
Cefixime. DRUGBANK Online. [2024-06-28]. （原始内容存档于2024-07-07）.
Cefixime Trihydrate. pipelinepharma. [2024-06-28]. （原始内容存档于2024-06-28）.
Suprax- cefixime powder, for suspension. DailyMed. 2 January 2020 [23 April 2020]. （原始内容存档于2020-07-28）.
Abhigan Babu Shrestha, Abhigan Babu; Shrestha, Sajina. Cefixime induced Steven Johnson syndrome: A case report from Bangladesh. Annals of Medicine and Surgery. July 2022, 79 [2023]. doi:10.1016/j.amsu.2022.104089. （原始内容存档于2024-06-28）.
PRODUCT MONOGRAPH PrSUPRAX® (PDF). ODAN LABORATORIES LTD. 2020-03-17 [2024-06-28]. （原始内容存档 (PDF)于2024-06-28）.
Cefixime (Oral Route). Mayo Clinic. [2024-06-28]. （原始内容存档于2024-06-28）.
Notice to Readers: Discontinuation of Cefixime Tablets --- United States. CDC. [2024-06-28]. （原始内容存档于2024-06-28）.
Suprax: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [2020-04-23]. （原始内容存档于2020-07-27）.
Suprax: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [2020-04-23]. （原始内容存档于2020-07-27）.
Suprax: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [2020-04-23]. （原始内容存档于2020-07-27）.
Suprax: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [2020-04-23]. （原始内容存档于2020-07-27）.
Perur S. Fake drugs: the global industry putting your life at risk. Mosaic. 2018-10-30 [2018-12-13]. （原始内容存档于2020-04-11）.

worldcat.org

Grayson ML. Kucers' the use of antibiotics : a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs Seventh. Boca Raton. 2017. ISBN 978-1-315-15211-0. OCLC 1011357224.